Press Releases

Press Releases
Date Title and Summary View
Dec 5, 2010 BOUDRY, Switzerland, Dec 05, 2010 (BUSINESS WIRE) --Celgene International Sàrl (Nasdaq:CELG) today announced that data from a pivotal Phase II, multicenter, international, open-label study of romidepsin (ISTODAX®) in progressive or relapsed PTCL following prior ...
Dec 4, 2010 BOUDRY, Switzerland, Dec 04, 2010 (BUSINESS WIRE) --Celgene International Sàrl (NASDAQ: CELG) announced that clinical data from two investigational studies evaluating the use of REVLIMID® (lenalidomide) either with rituximab or following a rituximab-containing ...
Dec 4, 2010 BOUDRY, Switzerland, Dec 04, 2010 (BUSINESS WIRE) --Celgene International Sàrl (NASDAQ: CELG) announced that data evaluating combination therapy REVLIMID® (lenalidomide) and dexamethasone in patients with high-risk asymptomatic smoldering multiple myeloma...
Nov 30, 2010 BOUDRY, Switzerland, Nov 30, 2010 (BUSINESS WIRE) -- Celgene International Sàrl (NASDAQ: CELG) today announced that clinical investigators from leading cancer research centers will present data from recent and on-going clinical trials in more than 260 posters and presentations, including more than 65 oral presentations evaluating Celgene ...
Nov 26, 2010 SUMMIT, N.J., Nov 26, 2010 (BUSINESS WIRE) -- Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 22nd Annual Piper Jaffray Health Care Conference on Tuesday, November 30, 2010 at 9:00 a.m. ET will be webcast live and will be available in the investor relations section of the company's Web site at ...
Nov 9, 2010 SUMMIT, N.J., Nov 09, 2010 (BUSINESS WIRE) --Celgene Corporation (NASDAQ: CELG) today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the company's Web site at ...
Oct 29, 2010 SUMMIT, N.J., Oct 29, 2010 (BUSINESS WIRE) --Celgene Corporation (NASDAQ: CELG) today announced its presentation at Oppenheimer's 21st Annual Healthcare Conference on Tuesday, November 2, 2010 at 11:25 a.m. ET will be webcast live and will be available in the investor relations section of the ...
Oct 28, 2010 SUMMIT, N.J., Oct 28, 2010 (BUSINESS WIRE) --Celgene Corporation (NASDAQ: CELG): 2010 Third Quarter Financial Results Year-Over-Year Non-GAAP Total Revenue Increased 31 Percent to $908 Million...
Oct 18, 2010 SUMMIT, N.J., Oct 18, 2010 (BUSINESS WIRE) --Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, October 28, 2010 at 9 a.m. ET to discuss the company's third quarter 2010 financial and operational results. The webcast will be available in the i...
Oct 15, 2010 SUMMIT, N.J., Oct 15, 2010 (BUSINESS WIRE) -- Celgene Corporation (NASDAQ: CELG) today announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (CVR...
FirstPrevious ...
46
... NextLast
Add to Briefcase = add release to Briefcase